Findings from an expert panel meeting on NATROX® O₂

Authors: Keith Harding, Karen Cross, Hanna Kaufman, Harikrishna K. Ragavan Nair, Gregory Schultz, Ibby Younis
Wounds International, 2020
Citation: Harding, K, Cross, K., Kaufman, H., et al, 2020. Findings from an expert panel meeting on NATROX® Oxygen Wound Therapy. Wounds International, 11(1): 47-52.
Keywords: compliance, concordance, oxygen therapy, pain relief, quality of healing
A group of key opinion leaders met in Windsor, UK, on September 19, 2019 to discuss their use of NATROX® Oxygen Wound Therapy (Inotec AMD Ltd) and agree on tips for best practice. NATROX® O₂ is clinically proven as an effective, practical and patient-friendly treatment (Wounds UK, 2017; Wounds International, 2018a; Wounds UK, 2019). The focus of the discussion was on optimising outcomes through patient selection and tips for best usage in practice.
Agreed effects of NATROX® O₂ observed in practice:
- Reduced time to healing
- Reduced scarring
- Reduced pain
- Increased exudate levels observed in responders (first 2-3 weeks)
- Increased oxygen diffusion
- Increased Reactive Oxygen Species (ROS)
- Reduced anaerobes/bacterial load
- Increased patient engagement
Key takeaways
- NATROX® O₂ topical oxygen wound therapy has a huge potential to improve outcomes and lives of suitable patients.
- Good for patients not suitable for, or do not have access to hyperbaric oxygen therapy (HBOT).
- Good for challenging anatomical locations.